Skip to main content
British Medical Journal logoLink to British Medical Journal
. 1978 Feb 11;1(6109):327–329. doi: 10.1136/bmj.1.6109.327

Atopy and immunoglobulin E concentrations in Hodgkin's disease and other lymphomas.

P L Amlot, L A Green
PMCID: PMC1602883  PMID: 623979

Abstract

Serum immunoglobulin E (IgE) concentrations are increased in Hodgkin's disease (HD) but not in other types of lymphoma. The prevalence of atopic disease is similar to normal in both groups. Patients with high IgE concentrations and HD were separated into atopic and non-atopic groups, which were found to differ clinically. Atopic patients had a significantly lower incidence of night sweats, fever, and weight loss, and treatment had no significant lasting effect on their IgE concentrations. In the non-atopic group there was a striking correlation between high IgE concentrations and a histological appearance of nodular sclerosis, particularly in the presence of night sweats, fever, and weight loss. Successful treatment in the non-atopic group led to a noticeable fall in IgE concentrations, in most cases to normal, though on relapse of the disease they rose again.

Full text

PDF
327

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Carbone P. P., Kaplan H. S., Musshoff K., Smithers D. W., Tubiana M. Report of the Committee on Hodgkin's Disease Staging Classification. Cancer Res. 1971 Nov;31(11):1860–1861. [PubMed] [Google Scholar]
  2. DWORIN M., DIAMOND H. D., CRAVER L. F. Hodgkin's disease and allergy. Cancer. 1955 Jan-Feb;8(1):128–131. doi: 10.1002/1097-0142(1955)8:1<128::aid-cncr2820080117>3.0.co;2-t. [DOI] [PubMed] [Google Scholar]
  3. Devita V. T., Jr, Serpick A. A., Carbone P. P. Combination chemotherapy in the treatment of advanced Hodgkin's disease. Ann Intern Med. 1970 Dec;73(6):881–895. doi: 10.7326/0003-4819-73-6-881. [DOI] [PubMed] [Google Scholar]
  4. Jarrett E. E., Stewart D. C. Potentiation of rat reaginic (IgE) antibody by helminth infection. Simultaneous potentiation of separate reagins. Immunology. 1972 Nov;23(5):749–755. [PMC free article] [PubMed] [Google Scholar]
  5. Johansson S. G. Raised levels of a new immunoglobulin class (IgND) in asthma. Lancet. 1967 Nov 4;2(7523):951–953. doi: 10.1016/s0140-6736(67)90792-1. [DOI] [PubMed] [Google Scholar]
  6. McCormick D. P., Ammann A. J., Ishizaka K., Miller D. G., Hong R. A study of allergy in patients with malignant lymphoma and chronic lymphocytic leukemia. Cancer. 1971 Jan;27(1):93–99. doi: 10.1002/1097-0142(197101)27:1<93::aid-cncr2820270114>3.0.co;2-0. [DOI] [PubMed] [Google Scholar]
  7. McKee W. D., Arnold C. A., Perlman M. D. A double-blind study of the comparative incidence of malignancy and allergy. J Allergy. 1967 May;39(5):294–301. doi: 10.1016/0021-8707(67)90093-7. [DOI] [PubMed] [Google Scholar]
  8. McLaughlan P., Stanworth D. R. A critical search for evidence of changes in levels of circulating IgE in patients with cancer. Lancet. 1975 Jan 11;1(7898):64–65. doi: 10.1016/s0140-6736(75)91071-5. [DOI] [PubMed] [Google Scholar]
  9. Nye L., Merrett T. G., Landon J., White R. J. A detailed investigation of circulating IgE levels in a normal population. Clin Allergy. 1975 Mar;5(1):13–24. doi: 10.1111/j.1365-2222.1975.tb01832.x. [DOI] [PubMed] [Google Scholar]
  10. Ochiai T., Okumura K., Tada T., Iwasa S. Effect of lymphocytosis-promoting factor of Bordetella pertussis on the immune response. I. Suppression of cellular hypersensitivity reactions. Int Arch Allergy Appl Immunol. 1972;43(2):196–206. doi: 10.1159/000230837. [DOI] [PubMed] [Google Scholar]
  11. Tada T. Regulation of reaginic antibody formation in animals. Prog Allergy. 1975;19:122–194. [PubMed] [Google Scholar]
  12. Winters W. D., Heiner D. C. IgE levels in sera of cancer patients. J Allergy Clin Immunol. 1976 Feb;57(2):181–186. doi: 10.1016/0091-6749(76)90039-7. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES